139 related articles for article (PubMed ID: 9577289)
1. Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates.
Kuusela AL
Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F151-3. PubMed ID: 9577289
[TBL] [Abstract][Full Text] [Related]
2. Gastric pH control in critically ill children receiving intravenous ranitidine.
Harrison AM; Lugo RA; Vernon DD
Crit Care Med; 1998 Aug; 26(8):1433-6. PubMed ID: 9710105
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
5. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
6. Alteration of normal gastric flora in neonates receiving ranitidine.
Cothran DS; Borowitz SM; Sutphen JL; Dudley SM; Donowitz LG
J Perinatol; 1997; 17(5):383-8. PubMed ID: 9373844
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients.
Kuusela AL; Ruuska T; Karikoski R; Laippala P; Ikonen RS; Janas M; Mäki M
Crit Care Med; 1997 Feb; 25(2):346-51. PubMed ID: 9034275
[TBL] [Abstract][Full Text] [Related]
8. Continuous intragastric pH measurement in the critically ill and treatment with parenteral ranitidine.
Albin M; Friedlos J; Hillman K
Intensive Care Med; 1985; 11(6):295-9. PubMed ID: 3878851
[TBL] [Abstract][Full Text] [Related]
9. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care.
Mäki M; Ruuska T; Kuusela AL; Karikoski-Leo R; Ikonen RS
Crit Care Med; 1993 Dec; 21(12):1863-7. PubMed ID: 8252891
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns.
Terrin G; Passariello A; De Curtis M; Manguso F; Salvia G; Lega L; Messina F; Paludetto R; Canani RB
Pediatrics; 2012 Jan; 129(1):e40-5. PubMed ID: 22157140
[TBL] [Abstract][Full Text] [Related]
12. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
13. Gastric pH and intravenous ranitidine in critically ill children.
López-Herce J; Vicente PE
Crit Care Med; 2000 Jan; 28(1):288-9. PubMed ID: 10667558
[No Abstract] [Full Text] [Related]
14. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
Aanpreung P; Vanprapar N; Susiva C; Parkpreaw C; Boonyachart C
J Med Assoc Thai; 1998 Mar; 81(3):185-9. PubMed ID: 9623009
[TBL] [Abstract][Full Text] [Related]
15. Control and variability of gastric pH in critically ill children.
Gedeit RG; Weigle CG; Havens PL; Werlin SL
Crit Care Med; 1993 Dec; 21(12):1850-5. PubMed ID: 8252889
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
17. Effect of ranitidine on gastric intramucosal pH in critically ill patients.
Calvet X; Baigorri F; Duarte M; Saura P; Royo C; Joseph D; Mas A; Artigas A
Intensive Care Med; 1998 Jan; 24(1):12-7. PubMed ID: 9503217
[TBL] [Abstract][Full Text] [Related]
18. [Continuous intragastric pH measurement in intensive care patients treated with ranitidine and tube feeding].
Krier C; Böhrer H; Jürs G; Warth S; Just OH
Anasth Intensivther Notfallmed; 1990 Jan; 25 Suppl 1():10-3. PubMed ID: 2106804
[TBL] [Abstract][Full Text] [Related]
19. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine is unable to maintain gastric pH levels above 4 in septic patients.
Terzi Coelho CB; Dragosavac D; Coelho Neto JS; Montes CG; Guerrazzi F; Andreollo NA
J Crit Care; 2009 Dec; 24(4):627.e7-13. PubMed ID: 19931156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
